Vanda Pharmaceuticals (VNDA) Reports In-Line Q2 EPS

August 4, 2011 8:13 AM EDT
Get Alerts VNDA Hot Sheet
Price: $5.31 +0.95%

Financial Fact:
Product sales: 38.48M

Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $8.07 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings